Emory University/The Emory Clinic

Atlanta, Georgia 30324

0 studies enrolling now · 2 studies all time

What they study most

Idiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension

Studies at this site

• Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early
• Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 — Stopped early